EU Promotes Collaboration

Research and funding organizations pledge to support a new system to support cross-border collaboration within the European Union.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The European Commission, in concert with key research organizations and funding agencies in the European Union (EU), yesterday (July 17) signed a statement and memorandum of understanding pledging to help EU researchers cross European borders to conduct research—a long-standing goal of many EU organizations that have pushed for the creation of the European Research Area (ERA).

“Today marks an important milestone and a basis for a new era," Máire Geoghegan-Quinn, EU commissioner for research, innovation, and science, declared at yesterday’s ceremony in Brussels. "The ERA is an idea whose time has come."

“Almost 80 percent of the research community has indicated that a lack of open and transparent recruitment hinders international mobility,” Robert-Jan Smits, the European director general for research, added at a press conference. “We are asking member states to step up the pursuit of joint research agendas, enhance competitive funding for institutions and projects and invest efficiently in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo